4//SEC Filing
Sullivan Lara 4
Accession 0001140361-22-012924
CIK 0001782223other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:15 PM ET
Size
4.6 KB
Accession
0001140361-22-012924
Insider Transaction Report
Form 4
Sullivan Lara
DirectorPresident ,CEO & CMO
Transactions
- Award
Common Stock
2022-03-31+742,574→ 1,041,363 total
Footnotes (1)
- [F1]Represents restricted stock units that vest over a four-year period, with 25% vesting on the first anniversary of the grant date, and the remaining 75% vesting in 12 substantially-equal quarterly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.
Documents
Issuer
Pyxis Oncology, Inc.
CIK 0001782223
Entity typeother
Related Parties
1- filerCIK 0001769457
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 4:15 PM ET
- Size
- 4.6 KB